Ertumaxomab van de graad van onderzoek

Bispecific, MusmusG2akappa, anti-ERBB2 (250A/TP-A-02) /Ratsp.G2blambda, anti-CD3E (26/II/6-1.2), TPBs03, CAS:509077-99-0

Mammalian Cells

P185erbB2, HER2, NGL, Tyrosinekinase-typecellsurfacereceptorHER2, NEU, MLN19, Proto-oncogeneNeu, MLN19, ERBB2, Proto-oncogenec-ErbB-2, CD340, Receptortyrosine-proteinkinaseerbB-2, Metastaticlymphnodegene19protein, T3E, T-cellsurfaceantigenT3/Leu-4epsilonchain, CD3e, CD3E, T-cellsurfaceglycoproteinCD3epsilonchain

ELISA, Bioactivity: FACS, Functional assay, Research in vivo

Protein A/G purified from cell culture supernatant.

1.39mg/ml

Please contact with the lab for this information.

>95% as determined by SDS-PAGE.

Liquid

0.01M PBS, pH7.4.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at4°C short term (1-2weeks) . Store at-20°C 12 months. Store at -372°C long term.

For research use only. Not suitable for clinical or therapeutic use.

0.01M PBS, pH7.4.

Human

IgG1-kappa